Soar Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 25-12-2024
- Paid Up Capital ₹ 0.20 M
as on 25-12-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Revenue -35.06%
(FY 2020)
- Profit -42.91%
(FY 2020)
- Ebitda 252.20%
(FY 2020)
- Net Worth 45.64%
(FY 2020)
- Total Assets -12.20%
(FY 2020)
About Soar Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Hemant Bhise, Sidda Basavaiah, and Vandana Wagh serve as directors at the Company.
- CIN/LLPIN
U51909MH2016PTC284460
- Company No.
284460
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Aug 2016
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Soar Life Sciences Private Limited offer?
Soar Life Sciences Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Spinning Machinery, Automated Spinning Mill, Career Guidance & Admission Services, Educational Services, Diesel Engine Generator Set, DG Sets, Medical Consultancy Services, Health Care Consultancy Service.
Who are the key members and board of directors at Soar Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemant Bhise  | Director | 04-Aug-2016 | Current |
| Sidda Basavaiah | Additional Director | 14-Sep-2024 | Current |
| Vandana Wagh | Director | 04-Aug-2016 | Current |
Financial Performance of Soar Life Sciences.
Soar Life Sciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 35.06% decrease. The company also saw a substantial fall in profitability, with a 42.91% decrease in profit. The company's net worth Soared by an impressive increase of 45.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Soar Life Sciences?
In 2018, Soar Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Frutton Life Sciences And Agro Private LimitedActive 10 years 2 monthsVandana Wagh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Soar Life Sciences?
Unlock and access historical data on people associated with Soar Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Soar Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Soar Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
